To the full analysis
Shin-Etsu Chemical stock: growth
4063.TShin-Etsu Chemical reported $16.12B in revenue for fiscal 2026, up 0.5% on the prior year, up 11.5% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
3.6%
per year from 2007 to 2026, per share 4.4%
Earnings (Annual rate)
6.1%
per year from 2007 to 2026, per share 6.9%
Free cash flow (Annual rate)
7.8%
per year from 2007 to 2026, per share 8.6%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2021 | since 2016 | since 2007 | |
|---|---|---|---|
| Revenue | 11.5% | 7.2% | 3.6% |
| Revenue per share | 13.7% | 8.6% | 4.4% |
| Earnings | 10.1% | 12.3% | 6.1% |
| Earnings per share | 12.3% | 13.7% | 6.9% |
| Free cash flow | 16.8% | 10.3% | 7.8% |
| Free cash flow per share | 19.2% | 11.7% | 8.6% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $8.17B | $964.39M | $544.12M |
| 2008 | $7.06B | $720.4M | −$326.69M |
| 2009 | $7.52B | $968.9M | $418.81M |
| 2010 | $5.74B | $525.07M | $249.93M |
| 2011 | $6.63B | $626.93M | $626.02M |
| 2012 | $6.56B | $630.21M | $101.74M |
| 2013 | $6.42B | $661.97M | $969.63M |
| 2014 | $7.3B | $711.45M | $1.21B |
| 2015 | $7.86B | $805.31M | $981.55M |
| 2016 | $8.01B | $932.02M | $841.7M |
| 2017 | $7.75B | $1.1B | $976.69M |
| 2018 | $9.03B | $1.67B | $1.07B |
| 2019 | $9.98B | $1.94B | $1.09B |
| 2020 | $9.67B | $1.97B | $901.83M |
| 2021 | $9.37B | $1.84B | $1.03B |
| 2022 | $12.99B | $3.13B | $2.24B |
| 2023 | $17.59B | $4.43B | $3.08B |
| 2024 | $15.12B | $3.26B | $2.38B |
| 2025 | $16.04B | $3.34B | $2.77B |
| 2026 | $16.12B | $2.97B | $2.25B |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 13 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = ¥159.70)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 5 Dec 2025)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.